insulin delivery

By Dave Muoio April 12, 2018
Cambridge, Massachusetts-based Common Sensing, which specializes in connected containers for injectable medications, has raised $6.6 million in Series A funding. The round was led by Waterline Ventures, with New World Health, Royal Philips, and Haselmeier also participating. The funding will be used to accelerate manufacturing and commercial operations for Common Sensing’s GoCap, a dose and...

Editor's Pick